U.S. markets open in 8 hours 43 minutes

Biolidics Limited (8YY.SI)

SES - SES Delayed Price. Currency in SGD
Add to watchlist
0.3350-0.0150 (-4.29%)
As of 1:29PM SGT. Market open.
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in SGD

Valuation Measures

Premium required to access annual data
Premium required to access monthly data
Subscribe to Premium to download historical data
As of Date: 11/28/2020
Market Cap (intraday) 5
Enterprise Value 3
Trailing P/E
Forward P/E 1
PEG Ratio (5 yr expected) 1
Price/Sales (ttm)
Price/Book (mrq)
Enterprise Value/Revenue 3
Enterprise Value/EBITDA 6

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 343.40%
S&P500 52-Week Change 317.08%
52 Week High 30.8850
52 Week Low 30.1750
50-Day Moving Average 30.3069
200-Day Moving Average 30.3624

Share Statistics

Avg Vol (3 month) 32.56M
Avg Vol (10 day) 36.27M
Shares Outstanding 5264.05M
Float 110.36M
% Held by Insiders 161.83%
% Held by Institutions 13.51%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2019
Most Recent Quarter (mrq)Jun 30, 2020


Profit Margin -41.47%
Operating Margin (ttm)-37.40%

Management Effectiveness

Return on Assets (ttm)-11.38%
Return on Equity (ttm)-29.28%

Income Statement

Revenue (ttm)7.62M
Revenue Per Share (ttm)0.03
Quarterly Revenue Growth (yoy)573.40%
Gross Profit (ttm)955.75k
Net Income Avi to Common (ttm)-3.16M
Diluted EPS (ttm)-0.0130
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)8.69M
Total Cash Per Share (mrq)0.03
Total Debt (mrq)3.58M
Total Debt/Equity (mrq)33.23
Current Ratio (mrq)6.07
Book Value Per Share (mrq)0.04

Cash Flow Statement

Operating Cash Flow (ttm)-5.38M
Levered Free Cash Flow (ttm)-4.74M